Synthesis of Structural ADP-Ribose Analogues as Inhibitors for SARS-CoV-2 Macrodomain 1.
Org Lett
; 26(27): 5700-5704, 2024 Jul 12.
Article
em En
| MEDLINE
| ID: mdl-38935522
ABSTRACT
Protein adenosine diphosphate (ADP)-ribosylation is crucial for a proper immune response. Accordingly, viruses have evolved ADP-ribosyl hydrolases to remove these modifications, a prominent example being the SARS-CoV-2 NSP3 macrodomain, "Mac1". Consequently, inhibitors are developed by testing large libraries of small molecule candidates, with considerable success. However, a relatively underexplored angle in design pertains to the synthesis of structural substrate mimics. Here, we present the synthesis and biophysical activity of novel adenosine diphosphate ribose (ADPr) analogues as SARS-CoV-2 NSP3 Mac1 inhibitors.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Antivirais
/
Adenosina Difosfato Ribose
/
SARS-CoV-2
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article